However, in the Ts2Cje mouse model of DS overexpressing CST3 improved endosomal morphology and alleviated behavioural defects but does not alter CatB activity [34], indicating that increased abundance of this cystatin may also be insufficient to change CatB activity in the context of DS. This evidence concerns the gene TYRP1 and Dravet syndrome.